Aging with HIV

• Milic J, Russwurm M, Cerezales Calvino A, et al. Eur Geriatr Med. 2019;10:247 This article provides a comprehensive overview of all important findings of HIV aging cohorts. Steves CJ, Spector TD, Jackson SH. Ageing, genes, environment and epigenetics: what twin studies tell us now, and in the future. Age Ageing. 2012;41(5):581–6. Vasto S, Scapagnini G, Bulati M, Candore G, Castiglia L, Colonna-Romano G, et al. Biomarkers of aging. Front Biosci (Schol Ed). 2010;2(1):392–402. Cesari M, Calvani R, Marzetti E. Frailty in older persons. Clin Geriatr Med. 2017;33(3):293–303. Brothers TD, Kirkland S, Guaraldi G, et al. Frailty in people aging with human immunodeficiency virus (HIV) infection. J Infect Dis. 2014;210(8):1170–9 6. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–6. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman RB, editors. Designing clinical research: an epidemiologic approach. 2nd ed. Baltimore: Lippincott Williams and Wilkins; 2001. Chambers LA, Wilson MG, Rueda S, Gogolishvili D, Shi MQ, Rourke SB, et al. Evidence informing the intersection of HIV, aging and health: a scoping review. AIDS Behav. 2014;18(4):661–75. Lazarus JV, Nielsen KK. HIV and people 50 years old in Europe. HIV Med. 2010;11(7):479–81. Cooperman NA, Arnsten JH, Klein RS. Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev. 2007;19(4):321–33. CDC, Center for Disease Control and Prevention. HIV/ AIDS among Persons Aged 50 and Older. 2008. Mugavero MJ, Napravnik S, Cole SR, et al. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis. 2011;539:927–35. Wright ST, Hoy J, Mulhall B, et al. Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr. 2014;661:55–64. UNAIDS. Get on the fast-track, the life-cycle approach to HIV 2016. Available at: http://www.unaids.org/sites/default/files/media_asset/Get-on-the-Fast-Track_en.pdf. [Accessed 10 May 2019]. UNAIDS. AIDS data, 2016. Available at: http://aidsinfo.unaids.org/. [Accessed 10 May 2019]. Hontelez JA, de Vlas SJ, Baltussen R, Newell ML, Bakker R, Tanser F, et al. The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS. 2012;26(Suppl 1):S19–30. Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem Av, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–8. • Smit M, Cassidy R, Cozzi-Lepri A, et al. Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: a modelling study. PLoS One. 2017;12(10):e0186638 This article provides the information about future challenges in HIV care, giving the projections of burden of non-communicable diseases in the following decade. Guaraldi G. Compression of frailty at an older age an aging population infected with HIV: a “geriatric-HIV” modelling study, 19th international workshop on co-morbidities and adverse drug reactions in HIV, Milan 2017. Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis. 2015;60(4):627–38. De Francesco D, Wit FW, Bürkle A, Oehlke S, Kootstra NA, Winston A, et al. Do people living with HIV experience greater age advancement than their HIV-negative counterparts? AIDS. 2019;33(2):259–68. Nelson KN, Hui Q, Rimland D, Xu K, Freiberg MS, Justice AC, et al. Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV-positive, treatment-naive U.S. veterans. AIDS. 2017;31(4):571–5. Pereyra F, Lo J, Triant VA, Wei J, Buzon MJ, Fitch KV, et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS. 2012;26:2409–12. Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al. INSIGHT SMART study group. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780–90. Cobos Jiménez V, Wit FW, Joerink M, Maurer I, Harskamp AM, Schouten J, et al. T-cell activation independently associates with immune senescence in HIV-infected recipients of long-term antiretroviral treatment. J Infect Dis. 2016;214(2):216–25. Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353–60. Mitnitski A, Rockwood K. The rate of aging: the rate of deficit accumulation does not change over the adult life span. Biogerontology. 2016;17(1):199–204. https://doi.org/10.1007/s10522-015-9583-y. Rockwood K, Blodgett JM, Theou O, Sun MH, Feridooni HA, Mitnitski A, et al. A frailty index based on deficit accumulation quantifies mortality risk in humans and in mice. Sci Rep. 2017;7:43068. https://doi.org/10.1038/srep43068. Kim S, Myers L, Wyckoff J, Cherry KE, Jazwinski SM. The frailty index outperforms DNA methylation age and its derivatives as an indicator of biological age. GeroScience. 2017;39(1):83–92. https://doi.org/10.1007/s11357-017-9960-3. Althoff KN, Jacobson LP, Cranston RD, et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci. 2014 Feb;69(2):189–98. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56. Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. Greene M, Covinsky KE, Valcour V, Miao Y, Madamba J, Lampiris H, et al. Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr. 2015;69:161–7. Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep. 2014;11:279–90. Koroukian SM, Schiltz N, Warner DF, Sun J, Bakaki PM, Smyth KA, et al. Combinations of chronic conditions, functional limitations, and geriatric syndromes that predict health outcomes. J Gen Intern Med. 2016;31:630–7. US Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. 2016. https:// aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf, Assessed 10th May 2019. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011;53(11):1130–9. Buchacz K, Baker RK, Palella FJ, et al. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther. 2013;18:65–75. Van Spall HGC, Toren A, Kiss A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297:1233–40. Dodd KS, Saczynski JS, Zhao Y. Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc. 2011;59:506–11. Nozza S, Malagoli A, Maia L, Calcagno A, Focà E, De Socio G, et al. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. J Antimicrob Chemother. 2017;72(10):2879–86. European Medical Agency (EMA) Points to consider on frailty: evaluation instruments for baseline characterisation of clinical trial populations. May 2016:1–18 (https://www.ema.europa.eu/en/physical-frailty-instruments-baseline-characterisation-older-populations-clinical-trials), Assessed 10th May 2019. • Guaraldi G, Rockwood K. Geriatric-HIV medicine is born. Clin Infect Dise. 2017;65:507–9 This article discusses which features of geriatric medicine should be introduced to HIV care. Balducci L. Geriatric oncology. Crit Rev Oncol Hematol. 2003;46:211–20. Antonelli Incalzi R, Gemma A, Capparella O, Bernabei R, Sanguinetti C, Carbonin P. Continuous geriatric care in orthopedic wards: a valuable alternative to orthogeriatric units. Aging (Milano). 1993;5:207–16. Guaraldi G, Marcotullio S, Maserati R, Gargiulo M, Milic J, Franconi I, et al. The management of geriatric and frail HIV patients. A 2017 update from the Italian guidelines for the use of antiretroviral agents and the diagnostic clinical management of HIV-1 infected persons. J Frailty Aging. 2019;8(1):10–6. Singh HK, Del Carmen T, Freeman R, Glesby MJ, Siegler EL. From one syndrome to many: incorporating geriatric consultation into HIV care. Clin Infect Dis. 2017;65(3):501–6. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV Downloaded from https://aidsinfo.nih.gov/guidelines on 5/15/2019 Visit the AIDSinfo at https://aidsinfo.nih.gov/e-news. Accessed 15th 2019. EACS European AIDS Society Guideline 9.1. Available at http://www.eacsociety.org/files/2018_guidelines-9.1-english.pdf. Last visit 31 May 2019. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–72. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Amer Geriatr Soc. 2012; 60:616–631.